Opko Sees Huge Long-Term Impact From Prolor Deal

Aug. 21 (Bloomberg) -- Phillip Frost, chief executive officer of Opko Health Inc., talks about its share listing on the Tel Aviv Stock Exchange today and the acquisition of Israeli drugmaker Prolor Biotech Inc. He speaks with Elliott Gotkine on Bloomberg Television's "On the Move." (Source: Bloomberg)

Reliance Regains Rank After Phone Pricing
36:10 - Reliance Industries regained its rank as India's second most-valuable company on news its telecom unit will be dumping its free data plans. Bloomberg's Siddharth Philip reports on "Bloomberg Markets." (Source: Bloomberg)
  • AirAsia X's CEO Says We're Pretty Much Hedged for Fuel
  • Making the Case for a Fed Rate Hike in May
  • Full Show: What'd You Miss? (02/22)